Baricinix, also known as Baricitinib 4 mg, is a prescription medication commonly prescribed to treat rheumatoid arthritis, an autoimmune condition characterized by the body’s immune system attacking its own joints and internal organs. In this article, we will explore the various aspects of Baricinix, including its uses, potential in treating COVID-19, precautions, and side effects.
Understanding Baricinix (Baricitinib 4 mg):
Baricinix, available in the generic form as Baricitinib 4 mg, is a powerful medication designed to alleviate the symptoms associated with rheumatoid arthritis. Manufactured by Beacon Pharma Ltd. in Bangladesh, Baricinix is formulated as oral tablets, each containing 4 mg of the active ingredient.
Sorry, no records were found. Please adjust your search criteria and try again.
Sorry, unable to load the Maps API.